Revium Rx (RVRC) Retained Earnings (2024 - 2026)

Revium Rx (RVRC) posted Retained Earnings of $31.8 million for Q4 2025, up 4.59% sequentially from $30.4 million in Q4 2024, and up 4.59% YoY from $30.4 million in Q4 2024.

Revium Rx (RVRC) Retained Earnings (2024 - 2026) Analysis & Trends

Revium Rx has reported Retained Earnings for 2 years, with the latest figure at $31.8 million in Q4 2025.

  • Quarterly Retained Earnings rose 4.59% year-over-year to $31.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $31.8 million (up 4.59% YoY) and the FY2025 annual result came in at $31.8 million, up 4.59% from the prior year.
  • Retained Earnings rose to $31.8 million in Q4 2025 per RVRC's latest filing, from $30.4 million in the prior quarter.
  • Over five years, Retained Earnings peaked at $31.8 million in Q4 2025 and troughed at $30.4 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn -19.79 Mn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn 38.43 Mn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn 1.90 Bn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn -1.54 Bn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn 1.32 Bn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn -12.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn 4.02 Bn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn 1.04 Bn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn 1.41 Bn
10 Revium Rx 101.42 Mn 99.91 Mn - 31.89 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 31.89 Mn
Dec 31, 2025 31.78 Mn
Dec 31, 2024 30.39 Mn